CN108424909A - A kind of cilium assembly and regulation gene and its coding albumen, acquisition methods and application - Google Patents
A kind of cilium assembly and regulation gene and its coding albumen, acquisition methods and application Download PDFInfo
- Publication number
- CN108424909A CN108424909A CN201810210290.0A CN201810210290A CN108424909A CN 108424909 A CN108424909 A CN 108424909A CN 201810210290 A CN201810210290 A CN 201810210290A CN 108424909 A CN108424909 A CN 108424909A
- Authority
- CN
- China
- Prior art keywords
- cilium
- gene
- xap5
- assembly
- regulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004081 cilia Anatomy 0.000 title claims abstract description 108
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 67
- 230000033228 biological regulation Effects 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims abstract description 20
- 241000195493 Cryptophyta Species 0.000 claims abstract description 30
- 241000195585 Chlamydomonas Species 0.000 claims abstract description 28
- 239000013604 expression vector Substances 0.000 claims abstract description 16
- 230000035772 mutation Effects 0.000 claims abstract description 16
- 241000195597 Chlamydomonas reinhardtii Species 0.000 claims abstract description 10
- 238000003780 insertion Methods 0.000 claims abstract description 10
- 230000037431 insertion Effects 0.000 claims abstract description 10
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 8
- 230000007812 deficiency Effects 0.000 claims abstract description 5
- 239000002773 nucleotide Substances 0.000 claims abstract description 5
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 5
- 108091033319 polynucleotide Proteins 0.000 claims abstract description 4
- 102000040430 polynucleotide Human genes 0.000 claims abstract description 4
- 239000002157 polynucleotide Substances 0.000 claims abstract description 4
- 101000882217 Homo sapiens Protein FAM50A Proteins 0.000 claims abstract 7
- 102100038926 Protein FAM50A Human genes 0.000 claims abstract 3
- 210000004027 cell Anatomy 0.000 claims description 36
- 238000012216 screening Methods 0.000 claims description 12
- 239000002299 complementary DNA Substances 0.000 claims description 6
- 238000012408 PCR amplification Methods 0.000 claims description 5
- 238000010839 reverse transcription Methods 0.000 claims description 5
- UOZODPSAJZTQNH-UHFFFAOYSA-N Paromomycin II Natural products NC1C(O)C(O)C(CN)OC1OC1C(O)C(OC2C(C(N)CC(N)C2O)OC2C(C(O)C(O)C(CO)O2)N)OC1CO UOZODPSAJZTQNH-UHFFFAOYSA-N 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 4
- UOZODPSAJZTQNH-LSWIJEOBSA-N paromomycin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO UOZODPSAJZTQNH-LSWIJEOBSA-N 0.000 claims description 4
- 229960001914 paromomycin Drugs 0.000 claims description 4
- 238000010276 construction Methods 0.000 claims description 3
- 238000013461 design Methods 0.000 claims description 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 210000004885 white matter Anatomy 0.000 claims 1
- 201000010099 disease Diseases 0.000 abstract description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 13
- 238000011160 research Methods 0.000 abstract description 13
- 101150044508 key gene Proteins 0.000 abstract description 7
- 230000008844 regulatory mechanism Effects 0.000 abstract description 5
- 230000008676 import Effects 0.000 abstract description 3
- 230000007547 defect Effects 0.000 description 21
- 108020004414 DNA Proteins 0.000 description 11
- 239000000047 product Substances 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 101100446206 Schizosaccharomyces pombe (strain 972 / ATCC 24843) xap5 gene Proteins 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 238000001962 electrophoresis Methods 0.000 description 6
- 210000003495 flagella Anatomy 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 108091008146 restriction endonucleases Proteins 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 4
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 239000003292 glue Substances 0.000 description 4
- 238000005286 illumination Methods 0.000 description 4
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- 102000004243 Tubulin Human genes 0.000 description 3
- 108090000704 Tubulin Proteins 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 238000007664 blowing Methods 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000005611 electricity Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 108010015792 glycyllysine Proteins 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 239000003471 mutagenic agent Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000019491 signal transduction Effects 0.000 description 3
- VIINVRPKMUZYOI-DCAQKATOSA-N Arg-Met-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(O)=O VIINVRPKMUZYOI-DCAQKATOSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- NKLRYVLERDYDBI-FXQIFTODSA-N Glu-Glu-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O NKLRYVLERDYDBI-FXQIFTODSA-N 0.000 description 2
- HNVFSTLPVJWIDV-CIUDSAMLSA-N Glu-Glu-Gln Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O HNVFSTLPVJWIDV-CIUDSAMLSA-N 0.000 description 2
- KMSGYZQRXPUKGI-BYPYZUCNSA-N Gly-Gly-Asn Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC(N)=O KMSGYZQRXPUKGI-BYPYZUCNSA-N 0.000 description 2
- FGPLUIQCSKGLTI-WDSKDSINSA-N Gly-Ser-Glu Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O FGPLUIQCSKGLTI-WDSKDSINSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- WTZUSCUIVPVCRH-SRVKXCTJSA-N Lys-Gln-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N WTZUSCUIVPVCRH-SRVKXCTJSA-N 0.000 description 2
- MSSJJDVQTFTLIF-KBPBESRZSA-N Lys-Phe-Gly Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(O)=O MSSJJDVQTFTLIF-KBPBESRZSA-N 0.000 description 2
- 238000002123 RNA extraction Methods 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 229940099112 cornstarch Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 108010080575 glutamyl-aspartyl-alanine Proteins 0.000 description 2
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 2
- 108010009298 lysylglutamic acid Proteins 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 230000008447 perception Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical group CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- UCIYCBSJBQGDGM-LPEHRKFASA-N Ala-Arg-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)O)N UCIYCBSJBQGDGM-LPEHRKFASA-N 0.000 description 1
- TTXMOJWKNRJWQJ-FXQIFTODSA-N Ala-Arg-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N TTXMOJWKNRJWQJ-FXQIFTODSA-N 0.000 description 1
- XQGIRPGAVLFKBJ-CIUDSAMLSA-N Ala-Asn-Lys Chemical compound N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O XQGIRPGAVLFKBJ-CIUDSAMLSA-N 0.000 description 1
- GSCLWXDNIMNIJE-ZLUOBGJFSA-N Ala-Asp-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O GSCLWXDNIMNIJE-ZLUOBGJFSA-N 0.000 description 1
- WDIYWDJLXOCGRW-ACZMJKKPSA-N Ala-Asp-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WDIYWDJLXOCGRW-ACZMJKKPSA-N 0.000 description 1
- NKJBKNVQHBZUIX-ACZMJKKPSA-N Ala-Gln-Asp Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O NKJBKNVQHBZUIX-ACZMJKKPSA-N 0.000 description 1
- BLGHHPHXVJWCNK-GUBZILKMSA-N Ala-Gln-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O BLGHHPHXVJWCNK-GUBZILKMSA-N 0.000 description 1
- VJVQKGYHIZPSNS-FXQIFTODSA-N Ala-Ser-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCN=C(N)N VJVQKGYHIZPSNS-FXQIFTODSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- HJVGMOYJDDXLMI-AVGNSLFASA-N Arg-Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CCCNC(N)=N HJVGMOYJDDXLMI-AVGNSLFASA-N 0.000 description 1
- ITVINTQUZMQWJR-QXEWZRGKSA-N Arg-Asn-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O ITVINTQUZMQWJR-QXEWZRGKSA-N 0.000 description 1
- OGUPCHKBOKJFMA-SRVKXCTJSA-N Arg-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N OGUPCHKBOKJFMA-SRVKXCTJSA-N 0.000 description 1
- PHHRSPBBQUFULD-UWVGGRQHSA-N Arg-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)N PHHRSPBBQUFULD-UWVGGRQHSA-N 0.000 description 1
- PCQXGEUALSFGIA-WDSOQIARSA-N Arg-His-Trp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O PCQXGEUALSFGIA-WDSOQIARSA-N 0.000 description 1
- HJDNZFIYILEIKR-OSUNSFLBSA-N Arg-Ile-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O HJDNZFIYILEIKR-OSUNSFLBSA-N 0.000 description 1
- CVXXSWQORBZAAA-SRVKXCTJSA-N Arg-Lys-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCN=C(N)N CVXXSWQORBZAAA-SRVKXCTJSA-N 0.000 description 1
- UDSVWSUXKYXSTR-QWRGUYRKSA-N Asn-Gly-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O UDSVWSUXKYXSTR-QWRGUYRKSA-N 0.000 description 1
- UBGGJTMETLEXJD-DCAQKATOSA-N Asn-Leu-Met Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(O)=O UBGGJTMETLEXJD-DCAQKATOSA-N 0.000 description 1
- RZNAMKZJPBQWDJ-SRVKXCTJSA-N Asn-Lys-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N)N RZNAMKZJPBQWDJ-SRVKXCTJSA-N 0.000 description 1
- KRXIWXCXOARFNT-ZLUOBGJFSA-N Asp-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O KRXIWXCXOARFNT-ZLUOBGJFSA-N 0.000 description 1
- KVMPVNGOKHTUHZ-GCJQMDKQSA-N Asp-Ala-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KVMPVNGOKHTUHZ-GCJQMDKQSA-N 0.000 description 1
- TVVYVAUGRHNTGT-UGYAYLCHSA-N Asp-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(O)=O TVVYVAUGRHNTGT-UGYAYLCHSA-N 0.000 description 1
- NYQHSUGFEWDWPD-ACZMJKKPSA-N Asp-Gln-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)O)N NYQHSUGFEWDWPD-ACZMJKKPSA-N 0.000 description 1
- AHWRSSLYSGLBGD-CIUDSAMLSA-N Asp-Pro-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O AHWRSSLYSGLBGD-CIUDSAMLSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 208000012661 Dyskinesia Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- UICOTGULOUGGLC-NUMRIWBASA-N Gln-Asp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)N)N)O UICOTGULOUGGLC-NUMRIWBASA-N 0.000 description 1
- MAGNEQBFSBREJL-DCAQKATOSA-N Gln-Glu-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)N)N MAGNEQBFSBREJL-DCAQKATOSA-N 0.000 description 1
- OUBUHIODTNUUTC-WDCWCFNPSA-N Gln-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O OUBUHIODTNUUTC-WDCWCFNPSA-N 0.000 description 1
- ITYRYNUZHPNCIK-GUBZILKMSA-N Glu-Ala-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O ITYRYNUZHPNCIK-GUBZILKMSA-N 0.000 description 1
- CGYDXNKRIMJMLV-GUBZILKMSA-N Glu-Arg-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O CGYDXNKRIMJMLV-GUBZILKMSA-N 0.000 description 1
- RDPOETHPAQEGDP-ACZMJKKPSA-N Glu-Asp-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O RDPOETHPAQEGDP-ACZMJKKPSA-N 0.000 description 1
- JVSBYEDSSRZQGV-GUBZILKMSA-N Glu-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCC(O)=O JVSBYEDSSRZQGV-GUBZILKMSA-N 0.000 description 1
- XHUCVVHRLNPZSZ-CIUDSAMLSA-N Glu-Gln-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O XHUCVVHRLNPZSZ-CIUDSAMLSA-N 0.000 description 1
- VXQOONWNIWFOCS-HGNGGELXSA-N Glu-His-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCC(=O)O)N VXQOONWNIWFOCS-HGNGGELXSA-N 0.000 description 1
- KRRFFAHEAOCBCQ-SIUGBPQLSA-N Glu-Ile-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O KRRFFAHEAOCBCQ-SIUGBPQLSA-N 0.000 description 1
- QJVZSVUYZFYLFQ-CIUDSAMLSA-N Glu-Pro-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O QJVZSVUYZFYLFQ-CIUDSAMLSA-N 0.000 description 1
- SYWCGQOIIARSIX-SRVKXCTJSA-N Glu-Pro-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O SYWCGQOIIARSIX-SRVKXCTJSA-N 0.000 description 1
- PYTZFYUXZZHOAD-WHFBIAKZSA-N Gly-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CN PYTZFYUXZZHOAD-WHFBIAKZSA-N 0.000 description 1
- FIQQRCFQXGLOSZ-WDSKDSINSA-N Gly-Glu-Asp Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O FIQQRCFQXGLOSZ-WDSKDSINSA-N 0.000 description 1
- CUYLIWAAAYJKJH-RYUDHWBXSA-N Gly-Glu-Tyr Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 CUYLIWAAAYJKJH-RYUDHWBXSA-N 0.000 description 1
- UTYGDAHJBBDPBA-BYULHYEWSA-N Gly-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)CN UTYGDAHJBBDPBA-BYULHYEWSA-N 0.000 description 1
- NSTUFLGQJCOCDL-UWVGGRQHSA-N Gly-Leu-Arg Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N NSTUFLGQJCOCDL-UWVGGRQHSA-N 0.000 description 1
- NNCSJUBVFBDDLC-YUMQZZPRSA-N Gly-Leu-Ser Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O NNCSJUBVFBDDLC-YUMQZZPRSA-N 0.000 description 1
- JPVGHHQGKPQYIL-KBPBESRZSA-N Gly-Phe-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 JPVGHHQGKPQYIL-KBPBESRZSA-N 0.000 description 1
- HFPVRZWORNJRRC-UWVGGRQHSA-N Gly-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN HFPVRZWORNJRRC-UWVGGRQHSA-N 0.000 description 1
- OHUKZZYSJBKFRR-WHFBIAKZSA-N Gly-Ser-Asp Chemical compound [H]NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O OHUKZZYSJBKFRR-WHFBIAKZSA-N 0.000 description 1
- 208000025309 Hair disease Diseases 0.000 description 1
- 206010067265 Heterotaxia Diseases 0.000 description 1
- DCRODRAURLJOFY-XPUUQOCRSA-N His-Ala-Gly Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)NCC(O)=O DCRODRAURLJOFY-XPUUQOCRSA-N 0.000 description 1
- CNHSMSFYVARZLI-YJRXYDGGSA-N His-His-Thr Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CNHSMSFYVARZLI-YJRXYDGGSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- FTUZWJVSNZMLPI-RVMXOQNASA-N Ile-Met-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@@H]1C(=O)O)N FTUZWJVSNZMLPI-RVMXOQNASA-N 0.000 description 1
- FHPZJWJWTWZKNA-LLLHUVSDSA-N Ile-Phe-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N2CCC[C@@H]2C(=O)O)N FHPZJWJWTWZKNA-LLLHUVSDSA-N 0.000 description 1
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 1
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 1
- KFKWRHQBZQICHA-STQMWFEESA-N L-leucyl-L-phenylalanine Natural products CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KFKWRHQBZQICHA-STQMWFEESA-N 0.000 description 1
- TYYLDKGBCJGJGW-UHFFFAOYSA-N L-tryptophan-L-tyrosine Natural products C=1NC2=CC=CC=C2C=1CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 TYYLDKGBCJGJGW-UHFFFAOYSA-N 0.000 description 1
- YOZCKMXHBYKOMQ-IHRRRGAJSA-N Leu-Arg-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)O)N YOZCKMXHBYKOMQ-IHRRRGAJSA-N 0.000 description 1
- ZTLGVASZOIKNIX-DCAQKATOSA-N Leu-Gln-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N ZTLGVASZOIKNIX-DCAQKATOSA-N 0.000 description 1
- SEMUSFOBZGKBGW-YTFOTSKYSA-N Leu-Ile-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O SEMUSFOBZGKBGW-YTFOTSKYSA-N 0.000 description 1
- QESXLSQLQHHTIX-RHYQMDGZSA-N Leu-Val-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QESXLSQLQHHTIX-RHYQMDGZSA-N 0.000 description 1
- PNPYKQFJGRFYJE-GUBZILKMSA-N Lys-Ala-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O PNPYKQFJGRFYJE-GUBZILKMSA-N 0.000 description 1
- SJNZALDHDUYDBU-IHRRRGAJSA-N Lys-Arg-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(O)=O SJNZALDHDUYDBU-IHRRRGAJSA-N 0.000 description 1
- SWWCDAGDQHTKIE-RHYQMDGZSA-N Lys-Arg-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SWWCDAGDQHTKIE-RHYQMDGZSA-N 0.000 description 1
- YEIYAQQKADPIBJ-GARJFASQSA-N Lys-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)N)C(=O)O YEIYAQQKADPIBJ-GARJFASQSA-N 0.000 description 1
- GPJGFSFYBJGYRX-YUMQZZPRSA-N Lys-Gly-Asp Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O GPJGFSFYBJGYRX-YUMQZZPRSA-N 0.000 description 1
- WBSCNDJQPKSPII-KKUMJFAQSA-N Lys-Lys-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O WBSCNDJQPKSPII-KKUMJFAQSA-N 0.000 description 1
- BXPHMHQHYHILBB-BZSNNMDCSA-N Lys-Lys-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O BXPHMHQHYHILBB-BZSNNMDCSA-N 0.000 description 1
- IKXQOBUBZSOWDY-AVGNSLFASA-N Lys-Val-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CCCCN)N IKXQOBUBZSOWDY-AVGNSLFASA-N 0.000 description 1
- DYTWOWJWJCBFLE-IHRRRGAJSA-N Met-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)CC1=CNC=N1 DYTWOWJWJCBFLE-IHRRRGAJSA-N 0.000 description 1
- PNHRPOWKRRJATF-IHRRRGAJSA-N Met-Tyr-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(O)=O)CC1=CC=C(O)C=C1 PNHRPOWKRRJATF-IHRRRGAJSA-N 0.000 description 1
- 102000029749 Microtubule Human genes 0.000 description 1
- 108091022875 Microtubule Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
- PESQCPHRXOFIPX-UHFFFAOYSA-N N-L-methionyl-L-tyrosine Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 PESQCPHRXOFIPX-UHFFFAOYSA-N 0.000 description 1
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- DJPXNKUDJKGQEE-BZSNNMDCSA-N Phe-Asp-Phe Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O DJPXNKUDJKGQEE-BZSNNMDCSA-N 0.000 description 1
- JJHVFCUWLSKADD-ONGXEEELSA-N Phe-Gly-Ala Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](C)C(O)=O JJHVFCUWLSKADD-ONGXEEELSA-N 0.000 description 1
- MIICYIIBVYQNKE-QEWYBTABSA-N Phe-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N MIICYIIBVYQNKE-QEWYBTABSA-N 0.000 description 1
- RMKGXGPQIPLTFC-KKUMJFAQSA-N Phe-Lys-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O RMKGXGPQIPLTFC-KKUMJFAQSA-N 0.000 description 1
- AGTHXWTYCLLYMC-FHWLQOOXSA-N Phe-Tyr-Glu Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C1=CC=CC=C1 AGTHXWTYCLLYMC-FHWLQOOXSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- CQZNGNCAIXMAIQ-UBHSHLNASA-N Pro-Ala-Phe Chemical compound C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccccc1)C(O)=O CQZNGNCAIXMAIQ-UBHSHLNASA-N 0.000 description 1
- RMODQFBNDDENCP-IHRRRGAJSA-N Pro-Lys-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O RMODQFBNDDENCP-IHRRRGAJSA-N 0.000 description 1
- IIRBTQHFVNGPMQ-AVGNSLFASA-N Pro-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@@H]1CCCN1 IIRBTQHFVNGPMQ-AVGNSLFASA-N 0.000 description 1
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- IFPBAGJBHSNYPR-ZKWXMUAHSA-N Ser-Ile-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O IFPBAGJBHSNYPR-ZKWXMUAHSA-N 0.000 description 1
- GZSZPKSBVAOGIE-CIUDSAMLSA-N Ser-Lys-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O GZSZPKSBVAOGIE-CIUDSAMLSA-N 0.000 description 1
- RRVFEDGUXSYWOW-BZSNNMDCSA-N Ser-Phe-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O RRVFEDGUXSYWOW-BZSNNMDCSA-N 0.000 description 1
- KKKVOZNCLALMPV-XKBZYTNZSA-N Ser-Thr-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O KKKVOZNCLALMPV-XKBZYTNZSA-N 0.000 description 1
- LGIMRDKGABDMBN-DCAQKATOSA-N Ser-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N LGIMRDKGABDMBN-DCAQKATOSA-N 0.000 description 1
- 208000031733 Situs inversus totalis Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- YZUWGFXVVZQJEI-PMVVWTBXSA-N Thr-Gly-His Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N)O YZUWGFXVVZQJEI-PMVVWTBXSA-N 0.000 description 1
- GXUWHVZYDAHFSV-FLBSBUHZSA-N Thr-Ile-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GXUWHVZYDAHFSV-FLBSBUHZSA-N 0.000 description 1
- IHAPJUHCZXBPHR-WZLNRYEVSA-N Thr-Ile-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N IHAPJUHCZXBPHR-WZLNRYEVSA-N 0.000 description 1
- AKHDFZHUPGVFEJ-YEPSODPASA-N Thr-Val-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O AKHDFZHUPGVFEJ-YEPSODPASA-N 0.000 description 1
- PWONLXBUSVIZPH-RHYQMDGZSA-N Thr-Val-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N)O PWONLXBUSVIZPH-RHYQMDGZSA-N 0.000 description 1
- KZTLZZQTJMCGIP-ZJDVBMNYSA-N Thr-Val-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KZTLZZQTJMCGIP-ZJDVBMNYSA-N 0.000 description 1
- MHNHRNHJMXAVHZ-AAEUAGOBSA-N Trp-Asn-Gly Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)O)N MHNHRNHJMXAVHZ-AAEUAGOBSA-N 0.000 description 1
- MDDYTWOFHZFABW-SZMVWBNQSA-N Trp-Gln-Leu Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O)=CNC2=C1 MDDYTWOFHZFABW-SZMVWBNQSA-N 0.000 description 1
- JFDGVHXRCKEBAU-KKUMJFAQSA-N Tyr-Asp-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N)O JFDGVHXRCKEBAU-KKUMJFAQSA-N 0.000 description 1
- WAPFQMXRSDEGOE-IHRRRGAJSA-N Tyr-Glu-Gln Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O WAPFQMXRSDEGOE-IHRRRGAJSA-N 0.000 description 1
- WSFXJLFSJSXGMQ-MGHWNKPDSA-N Tyr-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N WSFXJLFSJSXGMQ-MGHWNKPDSA-N 0.000 description 1
- MDXLPNRXCFOBTL-BZSNNMDCSA-N Tyr-Ser-Tyr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O MDXLPNRXCFOBTL-BZSNNMDCSA-N 0.000 description 1
- XTAUQCGQFJQGEJ-NHCYSSNCSA-N Val-Gln-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N XTAUQCGQFJQGEJ-NHCYSSNCSA-N 0.000 description 1
- XGJLNBNZNMVJRS-NRPADANISA-N Val-Glu-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O XGJLNBNZNMVJRS-NRPADANISA-N 0.000 description 1
- KZKMBGXCNLPYKD-YEPSODPASA-N Val-Gly-Thr Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O KZKMBGXCNLPYKD-YEPSODPASA-N 0.000 description 1
- SDUBQHUJJWQTEU-XUXIUFHCSA-N Val-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](C(C)C)N SDUBQHUJJWQTEU-XUXIUFHCSA-N 0.000 description 1
- 210000001766 X chromosome Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 108010041407 alanylaspartic acid Proteins 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 108010008355 arginyl-glutamine Proteins 0.000 description 1
- 108010052670 arginyl-glutamyl-glutamic acid Proteins 0.000 description 1
- 108010029539 arginyl-prolyl-proline Proteins 0.000 description 1
- 108010062796 arginyllysine Proteins 0.000 description 1
- 108010038633 aspartylglutamate Proteins 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 208000030303 breathing problems Diseases 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000009087 cell motility Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 208000034653 disorder of pilosebaceous unit Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 108010006664 gamma-glutamyl-glycyl-glycine Proteins 0.000 description 1
- 238000012215 gene cloning Methods 0.000 description 1
- 108010019832 glycyl-asparaginyl-glycine Proteins 0.000 description 1
- 108010023364 glycyl-histidyl-arginine Proteins 0.000 description 1
- 108010089804 glycyl-threonine Proteins 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- -1 isopentyl aldehyde Chemical class 0.000 description 1
- 108010034529 leucyl-lysine Proteins 0.000 description 1
- 108010044056 leucyl-phenylalanine Proteins 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 108010003700 lysyl aspartic acid Proteins 0.000 description 1
- 108010044348 lysyl-glutamyl-aspartic acid Proteins 0.000 description 1
- 108010017391 lysylvaline Proteins 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 210000004688 microtubule Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000007523 nucleic acids Chemical group 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 108010024654 phenylalanyl-prolyl-alanine Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000012313 reversal agent Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 208000008797 situs inversus Diseases 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 108010005652 splenotritin Proteins 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 108010044292 tryptophyltyrosine Proteins 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/405—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from algae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention provides a kind of cilium assembly and regulation gene and its coding albumen, acquisition methods and application, for the gene source in Chlamydomonas reinhardtii, the Gene Name is XAP5, and the gene includes such as SEQ ID NO:CDNA sequence shown in 1;Or include SEQ ID NO:The polynucleotides of coded protein sequence shown in 2;Or comprising with SEQ ID NO:CDNA sequence defined by 1 has 90% or more homology and encodes the nucleotide sequence of identical function albumen.The present invention will be in VIII segment radom insertions to chlamydomonas of aph by electroporated method, obtain cilium assembling deficiency mutation algae strain af1 x, cilium assembly and regulation key gene XAP5 is obtained by identification, build chlamydomonas expression vector, and it imports in af1 x chlamydomonas, research finds that the function of mutation algae strain has obtained complementation, and cilium can be assembled normally.XAP5 genes of the present invention and its coding albumen can be further used for the research of the assembly and regulation mechanism of cilium and the research and treatment etc. of cilium relevant disease.
Description
Technical field
The present invention relates to biotechnologies, and in particular to a kind of cilium assembly and regulation gene and its coding albumen obtain
Methods and applications.
Background technology
Cilium is also known as flagellum, is that one kind is widely present in most of eukaryotic cells surface and has polar structure
Organelle.Cilium has certain perception effect, it can perceive the variation of extraneous some physics and chemical signal, and
By signal transduction to cell interior.Exactly because cilium has the function of more complex structure and signal transduction, therefore once lacks
It may result in the generation of cilium relevant disease, such as motionless disease, situs inversus viscerum, hypertension and the obesity of breathing problem, sperm
Disease etc..Cilium has very conservative structure.
The usually life of earliest unicellular organism in water, and has cilium.Cilium is mainly by cilium film, axial filament and fibre
Hair matrix three parts form.Cilium film is connected to cell membrane, is the extension of cell membrane, but not with the protein component of cell membrane
Together, axial filament is made of the cellular microtubules beam and its accessory protein that are assembled since matrix, and cilium matrix is mainly cilium film
Filler between axial filament, majority are soluble albumen.The main skeleton of cilium is micro- by 9 duplexes of cilium axial filament
Pipe forms, according to whether having motility, and cilium is divided into " 9+2 " sports type cilium and " 9+0 " not ejector half cilium (primary fibre
Hair).
It is understood that all having cilium in the puberty of embryo and many cells of adult, cilium is in cell
Movement and signal transduction tool play a very important role, and cilium has high complexity, once cilium is in structure or function
Defect occurs, then the development that will result in human body is abnormal and numerous diseases, people are by this disease caused by cilium
Disease is named " cilium relevant disease ".Cilium is divided into primary cilium, kinocilium, non-motile cilia, perception cilium etc., different types of fibre
Hair life defect will cause various " cilium relevant diseases ".
Chlamydomonas reinhardtii is a kind of single celled eucaryote, simple in structure, and breeding is fast.Defect is assembled by screening cilium
Chlamydomonas mutant, identification and clone's cilium regulate and control relevant key gene, study the assembly and regulation mechanism of cilium, will be that the mankind exist
It was found that, provide important theoretical foundation in terms of research and treatment cilium relevant disease.
Invention content
For the above problem in background technology, one of main object of the present invention is to provide a kind of cilium assembly and regulation
Gene derives from Chlamydomonas reinhardtii, can be further used for the research of assembly and regulation mechanism and the grinding for cilium relevant disease of cilium
Study carefully and treat etc..
In order to achieve the above object, the present invention adopts the following technical scheme that:A kind of cilium assembly and regulation gene derives from Lay
Mattress chlamydomonas, the Gene Name are XAP5 (X-chromosome-associated protein 5), and the gene includes such as
SEQ ID NO:CDNA sequence shown in 1;Or include SEQ ID NO:The polynucleotides of coded protein sequence shown in 2;
Or comprising with SEQ ID NO:CDNA sequence defined by 1 is with 90% or more homology and encodes identical function egg
White nucleotide sequence.
Another object of the present invention is to provide the acquisition methods of above-mentioned cilium assembly and regulation gene, include the following steps:
It will be in the VIII segment radom insertions to chlamydomonas of aph that encode paromomycin resistance by electroporated method;Pass through screening
Obtain cilium assembling deficiency mutation algae strain af1-x;It identifies to obtain the gene for cilium assembly and regulation by RESDA-PCR
XAP5。
As a further preference, the sequence of VIII segments of the aph such as SEQ ID NO:Shown in 3.
Another object of the present invention also resides in the coding albumen for providing above-mentioned cilium assembly and regulation gene, the coding albumen
Contain SEQ ID NO:Amino acid sequence shown in 2, or comprising by SEQ ID NO:Amino acid sequence shown in 2 is by multiple
What the the replacing, missing or adding of amino acid to be formed has identical active derived protein.
Another object of the present invention, which also resides in, provides the expression vector containing above-mentioned cilium assembly and regulation gene.
Another object of the present invention, which also resides in, provides the host cell containing above-mentioned cilium assembly and regulation gene.
Another object of the present invention also resides in the acquisition side for providing the expression vector containing above-mentioned cilium assembly and regulation gene
Method includes the following steps:
Wild type chlamydomonas RNA is extracted, reverse transcription obtains cDNA;Design primer obtains XAP5 genes by PCR amplification;It will
XAP5 genes are connected to intermediate carrier or chlamydomonas expression vector.
Another object of the present invention also resides in the acquisition side for providing the expression vector containing above-mentioned cilium assembly and regulation gene
Method includes the following steps:The artificial synthesized cilium assembly and regulation gene order, carrier construction.
In addition, obtain gene order of the present invention by artificial synthesized or other means, carrier construction or it is transferred to host
Cell, within protection scope of the present invention.
The beneficial effects of the invention are as follows:Cilium assembly and regulation gene of the present invention derives from Chlamydomonas reinhardtii, the Gene Name
Sequence for XAP5, the gene includes such as SEQ ID NO:CDNA sequence shown in 1;Or include SEQ ID NO:Shown in 2
Coded protein sequence polynucleotides;Or comprising with SEQ ID NO:CDNA sequence defined by 1 have 90% with
On homology and encode the nucleotide sequence of identical function albumen.What is identified in the present invention is related to cilium assembly and regulation
Gene XAP5 after, prove to restore the coding albumen of XAP5 in mutant by complementary assay and expressed, cilium phenotype is restored
Normally, it further demonstrates XAP5 and plays crucial effect in terms of regulating and controlling cilium assembling.Thus, it is provided in the present invention
XAP5 genes and its coding albumen are the key gene and albumen of cilium assembly and regulation, can be cilium assembly and regulation mechanism
Research, cilium defect cause the research of cilium disease and treatment to provide theoretical foundation.
It is lacked in addition, the present invention in VIII segment radom insertions to chlamydomonas of aph, will obtain cilium assembling by electroporated method
Swaged is mutated algae strain af1-x, obtains cilium assembly and regulation key gene XAP5 by identification, builds chlamydomonas expression vector, will wrap
The expression vector or host cell of the XAP5 containing gene imports the cilium assembling deficiency mutation algae strain (af1-x) that the present invention obtains
In, research finds that the function of mutation algae strain has obtained complementation, and cilium can be assembled normally.
Description of the drawings
Fig. 1 is that wild type (21gr), mutant (af1-x) and character restore algae strain (Rescued) comparison diagram.
Fig. 2 is READA-PCR product electrophoretograms.
Fig. 3 is XAP5 gene insertion mutations site schematic diagram.
Fig. 4 is the PCR electrophoretograms of XAP5 gene clonings.
Fig. 5 is XAP5 gene constructed to restriction enzyme digestion and electrophoresis figure after complementary expression vector.
Fig. 6 is the Western Blot detection figures that wild type chlamydomonas, mutant and character restore algae strain.
Specific implementation mode
The present invention passes through sieve by a kind of cilium assembly and regulation gene of offer and its coding albumen, acquisition methods and application
The chlamydomonas mutant of cilium assembling defect, identification and clone's cilium is selected to regulate and control relevant key gene, study the group adjustment of cilium
Control mechanism provides important theoretical foundation for the mankind in terms of discovery, research and treatment cilium relevant disease.
In order to which be more clear the present invention sets forth, the researcher for being related to this field is allowed to be better understood when this
A invention will be illustrated below by several embodiments, but just for the sake of it can be preferably understood, of the invention makes
It is not intended to limit herein with range.In following embodiment, specified otherwise is not all conventional method.
Embodiment one:The screening of Chlamydomonas reinhardtii cilium defect mutant
The screening of Chlamydomonas reinhardtii cilium defect mutant, including step in detail below:
The preparation of 1.1 Insert Fragments
VIII carriers of pJMG-aph (are mainly transformed by pSI103, resistance containing paromomycin), enzyme is carried out with I enzymes of EcoR
It cuts, different size of DNA fragmentation is detached by DNA agarose gel electrophoresis, gel extraction is carried out to target fragment (aph VIII).
Glue recycling carries out glue reclaimer operation to specifications using SanPrep gel extraction kits.
The preparation of 1.2 reinhardtii cells
Wild type algae strain (21gr) on TAP solid plates is inoculated into TAP fluid nutrient mediums, is placed under continuous illumination
Culture of blowing can reach 1 × 10 in 3-4 days7Cell/ml.The above-mentioned reinhardtii cells of 10ml are taken to be forwarded to the Liquid Cultures of TAP containing 100ml
It is 1 × 10 to make initial concentration in the triangular flask of base6Cell/ml is placed on shaking table (200rpm), is cultivated under the conditions of continuous illumination
20h or so makes reinhardtii cell concentration reach 5 × 106Cell/ml carries out electrotransformation experiment immediately.
1.3 electroporated acquisition transformants
Reinhardtii cell is collected with 50ml centrifuge tubes, the TAP+60mM sorbitol solutions that precooling is added are resuspended, 2500rpm centrifugations
3min, the TAP+60mM sorbierites for adding suitable precooling are resuspended, and make final concentration of 1-2 × 10 of reinhardtii cell8Cell/
Ml places 10min on ice.
In superclean bench wash-in shock by electricity cup, first washed once with absolute ethyl alcohol, then with TAP+60mM sorbierites wash three times, with
Precooling electric shock cup afterwards.Precooled 1-2 × 10 250 μ l are added into electric shock cup8The reinhardtii cell of cell/ml, adds 60-
VIII segment DNA of 100ng aph is gently inhaled and beats mixing, in placing 10min on ice.Adjust electric shock instrument (model BTX ECM630)
Parameter is voltage 800V, 1575 Ω of resistance, 50 μ F of capacitance.The moisture for drying electric shock cup shell makes electric shock cup carry metal strip
The electric shock clamping connection of both sides and electric shock instrument touches and clamps electric shock cup, puts down safety guard, and starting electric shock, (the electric shock time should control in 10-
14ms).After electric shock, electric shock cup is placed into 10min on ice.
Reinhardtii cell after electric shock is transferred in the 50ml centrifuge tubes containing 10ml TAP+60mM sorbitol solutions, is placed in
100rpm, dim light reparation are stayed overnight on shaking table.
2500rpm centrifugations 3min collects the reinhardtii cell repaired overnight, and cornstarch (the starch nothing of 1ml 20% is added
Water-ethanol is washed 1 time, then is washed 3 times with sterile distilled water, is finally washed 4 times with TAP+60mM sorbierites, TAP+60mM sorbierites are used in combination
It is resuspended.), mixing is beaten in suction, is laid on the TAP solid plates containing paromomycin, liquid is dried up in superclean bench, is sealed
Mouthful, it is inverted under the photoperiod and cultivates, transformant can be grown within about 7 days or so.
The screening of 1.4 cilium defect mutant
After above-mentioned transformant is grown well (or so about one week), monoclonal is chosen to another new TAP solid
On culture medium, and carry out number.It after new transformant is grown well, chooses into 96 orifice plates containing M culture mediums and cultivates, then aobvious
The cell of dyskinesia, the as mutant of ciliary movement defect are observed and recorded under micro mirror.
1.5 ciliums assemble the acquisition of defect mutation algae strain af1-x
The embodiment of the present invention obtains a collection of chlamydomonas transformant, into one by electroporated VIII segments of method radom insertion aph
The screening for carrying out cilium defect mutant to the transformant of acquisition is walked, cilium assembling defect mutation algae strain af1-x has been obtained.
DIC microscopically observations find (shown in Fig. 1):Compared with wild type chlamydomonas 21gr, af1-x be mutated algae strain in agglomerate state and
Atrichia can only grow very short flagellum with the autolysin processing af1-x algaes strain after cell wall that melts away.
Embodiment two:Chlamydomonas reinhardtii cilium assembles identification and the clone of the mutator of defect mutation algae strain af1-x
2.1 ciliums assemble the identification of defect mutant af1-x mutators
2.1.1 the extraction of af1-x genomic DNAs
(1) af1-x mutant is inoculated into toothpick in fresh R culture mediums, is cultivated to concentration about under the conditions of the photoperiod
It is 5 × 106It when cell/ml, collects in 4ml cells to the EP pipes of 1.5ml, supernatant is removed in centrifugation.
(2) the CTAB lysates of 700ul are added, blow and beat mixing cell, are placed on heating cracking 1h in 65 DEG C of water-bath, often
It is primary every the 10min mixings that turn upside down, so that cell is fully cracked.
(3) after cell fully cracks, isometric phenol, chloroform, isoamyl alcohol (25 is added:24:1) mixed solution, top
The EP of falling mixing pipe 10min, make it mix well, and 14000rpm centrifuges 10min.
(4) it sucts clearly in a new EP pipe, adds isometric chloroform, isoamyl alcohol (24:1) mixed solution,
Turn upside down EP pipe 10min, it is made to mix well, and 14000rpm centrifuges 10min.
(5) it draws in the supernatant to a new EP pipe after above-mentioned centrifugation, the isopropanol of 3/4ths volumes is added, mildly
Reverse EP pipes 10 times, then place 15-20min for -20 DEG C, until there is floccule precipitation.
(6) 14000rpm centrifuges 10min, discards supernatant, and the ethyl alcohol for being added 75% washs precipitation 3-5 times, every time
14000rpm centrifuges 5min, with pipettor exhaustion residual ethanol, dry DNA 5min after the washing of last time ethyl alcohol.
(7) ddH of 50 μ l is added2O dissolving DNAs, measure DNA concentration after it is spare.
2.1.2 READA-PCR identifies af1-x mutators
According to nucleic acid sequence (the SEQ ID NO of Insert Fragment aph VIII:3) special primer S1 and S2 are designed, according to chlamydomonas base
It is formed because of group feature design primer Q0 and by Q0 and AluI, PstI, SacII, TaqI restriction enzyme specific recognition sequence
Degenerate primer DegAluI, DegPstI, DegSacII, DegTaqI, primer specifying information are as follows:
Primer | 5′—3′ |
S1 | TTTTACCGGCTGTTGGAC |
S2 | AGTTCTTCTGAGGGACCTG |
Q0 | CCAGTGAGCAGAGTGACG |
DegAluI | CCAGTGAGCAGAGTGACGIIIIINNSWCAGCTT |
DegPstI | CCAGTGAGCAGAGTGACGIIIIINNSCTGCAGW |
DegSacII | CCAGTGAGCAGAGTGACGIIIIINNSCCGCGGW |
DegTaqI | CCAGTGAGCAGAGTGACGIIIIINNSWGTCGAA |
Different from common PCR, RESDA-PCR points are two-wheeled, specific as follows:
First round PCR system:Using af1-x mutant gene group DNA as template, with forward primer S1 and reverse primer
DegAluI, DegPstI, DegSacII, DegTaqI carry out PCR amplification respectively.
Second wheel amplification:Template is used as after first round PCR product is diluted 25 times, with forward primer S2 and reverse primer Q0
Carry out the second wheel PCR amplification.
The system and program of specific RESDA-PCR referring to David et al. research (David Gonz á lez-
Ballester,Amaury de Montaigu,Aurora Galván,Emilio Fernández.Restriction
enzyme site-directed amplification PCR:A tool to identify regions flanking a
marker DNA.Analytical Biochemistry 340(2005)330–335.)。
After second wheel PCR, the second wheel PCR product is subjected to electrophoresis on 1% Ago-Gel, cuts 500bp or more
Band sends to sequencing.Fig. 2 is that cilium according to the present invention assembles electrophoretograms of the defect mutant af1-x after RESDA-PCR,
Wherein A, P, S, T respectively represent the amplification of the degenerate primer containing AluI, PstI, SacII, TaqI restriction endonuclease recognition sequence
Product.
2.1.3 af1-x is mutated insertion mutation gene and the insertion mutation site of algae strain
READA-PCR products sequencing result is compared with chlamydomonas genome, it is found that the cilium in the present invention assembles defect
Mutant af1-x is since the last one introne of XAP5 genes on the 7th article of chromosome has been inserted into VIII segments of aph and causes
Insertion mutation, schematic diagram is as shown in Figure 3.
The clone of 2.2 XAP5 genes
2.2.1 the RNA extractions of Chlamydomonas reinhardtii (21gr)
Wild type chlamydomonas 21gr is chosen from solid panel to carrying out air blowing culture inside R culture mediums, when concentration 5-6 ×
106When cell/ml, culture 2-3 days inside new M culture mediums are transferred to, cell concentration is made to reach 6 × 106Cell/ml is collected
The EP of 1ml cells to 1.5ml are managed, and 14000rpm centrifuges 1min, abandons supernatant, liquid nitrogen flash freezer is placed on -80 DEG C and saves backup.
It is carried out using the plant total RNA extraction reagent box (Cat#RP3302) that Wuhan Bo Yue Bioisystech Co., Ltd produces
The extraction of RNA, concrete operation step reference reagent box specification.
2.2.2 reverse transcription obtains cDNA
The RNA of above-mentioned acquisition is obtained into cDNA through reverse transcription, the present invention uses the full formula gold biotechnology in Beijing limited
The step of reversal agents box (article No. Lot#I20818) of formula, specific reverse transcription, refers to product description.
2.2.3 the cDNA amplifications of XAP5 genes
Using the cDNA of 21gr as template, with XAP5-F, (primer sequence is:
CCGCTCGAGATGTATAGCAACGGTTATGTGGGCA, wherein underscore are labeled as I restriction enzyme sites of Xho) and XAP5-R (primers
Sequence is:GGAAGATCTGCCGTAGATGGTATACTCGCC, wherein underscore are labeled as II restriction enzyme sites of Bgl), HiFi Taq
Enzyme carries out PCR amplification.The agarose gel electrophoresis figure of XAP5 genes is shown in Fig. 4.Glue recycles target fragment, connects carrier T, and conversion is big
Enterobacteria competent cell DH5 α, choose positive colony and send to sequencing.Sequencing result and SEQ ID NO:1 is consistent.
Embodiment three:The character complementation test of chlamydomonas cilium defect mutant (af1-x, that is, xap5)
3.1 complementary expression vector establishments
The plasmid of pEV-AR4-Ble2A-HA zero loads and XAP5-T carriers is subjected to double digestion with Bgl II and I enzymes of Xho, electricity
Swimming detection digestion effect, glue recycles linear carrier segments and XAP5 segments, T4 DNA ligases are attached.10ul connections are produced
Object is transferred to by heat-shock transformed method in competent escherichia coli cell DH5 α, is sieved with the LB solid plates containing AMP resistances
Choosing, picking positive colony carry out shaking bacterium, extraction plasmid.The recombinant plasmid for taking 2 μ g carries out double digestion, enzyme with Bgl II and I enzymes of Xho
It cuts product and carries out 1% agarose gel electrophoresis detection, as a result show (Fig. 5):XAP5 genes are successfully building up to chlamydomonas expression vector
On, it is named as pEV-AR4-Ble2A-XAP5-HA.
3.2 characters restore the screening of algae strain
3.2.1 the preparation of mutant chlamydomonas af1-x competent cells
The strain of af1-x algaes is inoculated into TAP fluid nutrient mediums, is placed under continuous illumination culture 3-4 days of blowing, then by cell
It is forwarded in the triangular flask of the fluid nutrient mediums of TAP containing 100ml, initial concentration is 1 × 106Cell/ml, continuous illumination culture 20h
Left and right.Af1-x cells are collected with 50ml centrifuge tubes, the TAP+60mM sorbitol solutions that precooling is added are resuspended, 2500rpm centrifugations
3min, the TAP+60mM sorbierites for adding suitable precooling are resuspended, and make final concentration of 1-2 × 10 of reinhardtii cell8Cell/
Ml places 10min on ice.
3.2.2 recombinant plasmid is linearized
The recombinant plasmid pEV-AR4-Ble2A-XAP5-HA for taking 5 μ g to contain XAP5 genes is stayed overnight, linearly with I digestions of Xba
Change product with the SanPrep pillar PCR product purification kits of raw work to be purified.
3.2.3 electroporated
Precooled 1-2 × 10 250 μ l are added into the electric shock cup of precooling8The af1-x competent cells of cell/ml and 10
The recombinant DNA of μ l linearisations, suction beat mixing, place 10min on ice, shocked by electricity with electric shock instrument (BTX ECM630).After electric shock,
Electric shock cup is placed into 10min on ice, cell is transferred in the centrifuge tube of the sorbitol solution containing TAP+60mM, dim light on shaking table
It repairs overnight.
The cell repaired overnight is collected, the cornstarch of 1ml 20% is added, suction beats mixing, is laid in the resistance containing ble
TAP tablets, dry up liquid, and sealing is inverted culture, grows transformant within about 7 days.
3.2.4 the algae strain that screening character is restored
After son to be transformed is long good, monoclonal is chosen on new TAP tablets and numbering.After growth 3-4 days, monoclonal is chosen
Extremely cultivated in 96 orifice plates containing M culture mediums.Microscopically observation, record, the possibility for capableing of proper motion are exactly that character is restored
Algae strain.
3.3 characters restore further determining that for algae strain
3.3.1 the micro- sem observation characters of DIC restore the flagellum of algae strain
Wild type chlamydomonas (21gr), cilium assembling defect mutant (af1-x) and recovery algae strain are carried out in M culture mediums
Activation.It takes 100 μ l cells to be fixed with isopentyl aldehyde respectively, is observed under DIC microscopes.As shown in Figure 1, af1-x is prominent
Variant does not have flagellum or has very short flagellum, and the flagellum for restoring algae strain restores normal, does not have difference with wild type.
3.3.2 Western Blot detections
Picking wild type chlamydomonas (21gr), mutant (af1-x) are distinguished from solid plate and restore algae strain (xap5::
XAP5、xap5::XAP5-HA), blow and cultivate 3-4 days in R culture mediums, be forwarded in M culture mediums and continue culture 1-2 days.It receives
Collection 1 × 107Cell carries out Western Blot detections with XAP5 antibody, HA antibody and α-Tubulin antibody respectively.Electrophoresis knot
Fruit is as shown in Figure 6:By α-Tubulin antibody test Tubulin albumen and coomassie brilliant blue staining as a result, showing each sample
Between albumen applied sample amount it is consistent.In addition to mutant (af1-x, that is, xap5), wild type chlamydomonas restores algae strain (xap5::XAP5 and
xap5::XAP5-HA the XAP5 albumen in) has expression.With HA antibody tests, restore algae strain (xap5::XAP5-HA) also there is mesh
Mark band.Western Blot testing results further demonstrate the cilium of af1-x, and can not normally to assemble be due to XAP5 bases
Caused by mutation, XAP5 genes and its coding albumen play an important role in cilium assembly and regulation.
Technical solution in above-mentioned the embodiment of the present application, at least has the following technical effect that or advantage:
Cilium assembly and regulation gene of the present invention, derives from Chlamydomonas reinhardtii, and the Gene Name is XAP5, the sequence of the gene
Row are comprising such as SEQ ID NO:CDNA sequence shown in 1;Or include SEQ ID NO:Coded protein sequence shown in 2 it is more
Nucleotide;Or comprising with SEQ ID NO:CDNA sequence defined by 1 is with 90% or more homology and encodes phase
The nucleotide sequence of congenerous albumen.Identified in the present invention with after the relevant gene XAP5 of cilium assembly and regulation, by mutual
Mending experiment proves that the coding albumen for restoring XAP5 in mutant is expressed, and cilium phenotype restores normal, further demonstrates
XAP5 plays crucial effect in terms of regulating and controlling cilium assembling.Thus, the XAP5 genes and its coding egg provided in the present invention
In vain, it is the key gene and albumen of cilium assembly and regulation, can be research, the cilium defect of cilium assembly and regulation mechanism leads to fibre
The research and treatment of hair disease provide theoretical foundation.
It is lacked in addition, the present invention in VIII segment radom insertions to chlamydomonas of aph, will obtain cilium assembling by electroporated method
Swaged is mutated algae strain af1-x, obtains cilium assembly and regulation key gene XAP5 by identification, builds chlamydomonas expression vector, will wrap
The expression vector or host cell of the XAP5 containing gene imports the cilium assembling deficiency mutation algae strain (af1-x) that the present invention obtains
In, research finds that the function of mutation algae strain has obtained complementation, and cilium can be assembled normally.
In addition, cilium defect mutant screening system provided in an embodiment of the present invention is easy to operate quickly, it is applied widely,
The screening of mutant can efficiently be carried out.After the mutant M fluid nutrient medium cultures that screening is obtained, directly under the microscope
Observation can simply, accurately screen the mutant of movement defect.
Although preferred embodiments of the present invention have been described, it is created once a person skilled in the art knows basic
Property concept, then additional changes and modifications may be made to these embodiments.So it includes excellent that the following claims are intended to be interpreted as
It selects embodiment and falls into all change and modification of the scope of the invention.Obviously, those skilled in the art can be to the present invention
Carry out various modification and variations without departing from the spirit and scope of the present invention.If in this way, these modifications and changes of the present invention
Within the scope of the claims of the present invention and its equivalent technology, then the present invention is also intended to exist comprising these modification and variations
It is interior.
Sequence table
<110>Jianghan University
<120>A kind of cilium assembly and regulation gene and its coding albumen, acquisition methods and application
<130> 2018
<160> 3
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1155
<212> DNA
<213> artifical sequence
<400> 1
atgtatagca acggttatgt gggcaccggc gaggatgtgc agcgcatccg gcgcatggag 60
aagcagcgcg aggaacagaa gaagaaatat gagcagatgc acaagcagac gaaagaccaa 120
gcggatgcgg cgggactcag gcaattcggc gcatccactg aggaggcgct agagcacgcg 180
ttcaagaacg agacggtggg cctggtcaca aaggcggagt tcatccagaa gcgcactacg 240
ctgcaggagc gtatggagga ggagcagcgg cgaaaggtgg aggcggacga ggacgcggcg 300
aacaaggagc gagagaagcg gaaacgggag aaggagttga gaaagcccaa gctcagcttc 360
tttgctgacg aggagcagga gggcgaggag gacgaggagg atgcccggcc gcctgtgaag 420
ccggccttca agctccctgc gctggcgcgg gtagcggcgg cggcgcagcc acccgagcca 480
gcggcggaca acggcgcggc cgcacggtca ggcagcgagg agccggcggg cagcgagggc 540
ggcaacggca gcgacggcgg caacggtttg tcgaagaagc agcgcaagtt cgggaaattc 600
ggcaaggacc caaccgtgac caccgacttc ctacccgaca aggaccggga gcggctggag 660
ctggagatgc gggcgcagct gcgcaaggag tggcagctgg cgcaggacgt gatcaaggcc 720
gagccgctca ccatcaccta ctcctactgg aacggcacag gacaccgccg caacgtgtcc 780
gtcaagaagg gcgactccat cggcggcttc ctcaaggccg tgcgcgagca gctggcgccc 840
gagttccgcg agctgcggca cgtgggcatc gacaacctca tgtacatcaa ggaagatttg 900
atcatgccgc accaccacac cttctacgag ctcatcatca gcaaggcgcg aggcaagtcg 960
ggcccgctgt ttgacttcac ggtcaaggac gacattcgca ttaccaacga cgccactcag 1020
gagaagcagg acacacacgc cggcaaggtg gtggagcgcc actggtacga caagaacaag 1080
cacatcttcc ccgccagccg ctgggagatt tacgatcccg agaagaagta cggcgagtat 1140
accatctacg gctga 1155
<210> 2
<211> 384
<212> PRT
<213> artifical sequence
<400> 2
Met Tyr Ser Asn Gly Tyr Val Gly Thr Gly Glu Asp Val Gln Arg Ile
1 5 10 15
Arg Arg Met Glu Lys Gln Arg Glu Glu Gln Lys Lys Lys Tyr Glu Gln
20 25 30
Met His Lys Gln Thr Lys Asp Gln Ala Asp Ala Ala Gly Leu Arg Gln
35 40 45
Phe Gly Ala Ser Thr Glu Glu Ala Leu Glu His Ala Phe Lys Asn Glu
50 55 60
Thr Val Gly Leu Val Thr Lys Ala Glu Phe Ile Gln Lys Arg Thr Thr
65 70 75 80
Leu Gln Glu Arg Met Glu Glu Glu Gln Arg Arg Lys Val Glu Ala Asp
85 90 95
Glu Asp Ala Ala Asn Lys Glu Arg Glu Lys Arg Lys Arg Glu Lys Glu
100 105 110
Leu Arg Lys Pro Lys Leu Ser Phe Phe Ala Asp Glu Glu Gln Glu Gly
115 120 125
Glu Glu Asp Glu Glu Asp Ala Arg Pro Pro Val Lys Pro Ala Phe Lys
130 135 140
Leu Pro Ala Leu Ala Arg Val Ala Ala Ala Ala Gln Pro Pro Glu Pro
145 150 155 160
Ala Ala Asp Asn Gly Ala Ala Ala Arg Ser Gly Ser Glu Glu Pro Ala
165 170 175
Gly Ser Glu Gly Gly Asn Gly Ser Asp Gly Gly Asn Gly Leu Ser Lys
180 185 190
Lys Gln Arg Lys Phe Gly Lys Phe Gly Lys Asp Pro Thr Val Thr Thr
195 200 205
Asp Phe Leu Pro Asp Lys Asp Arg Glu Arg Leu Glu Leu Glu Met Arg
210 215 220
Ala Gln Leu Arg Lys Glu Trp Gln Leu Ala Gln Asp Val Ile Lys Ala
225 230 235 240
Glu Pro Leu Thr Ile Thr Tyr Ser Tyr Trp Asn Gly Thr Gly His Arg
245 250 255
Arg Asn Val Ser Val Lys Lys Gly Asp Ser Ile Gly Gly Phe Leu Lys
260 265 270
Ala Val Arg Glu Gln Leu Ala Pro Glu Phe Arg Glu Leu Arg His Val
275 280 285
Gly Ile Asp Asn Leu Met Tyr Ile Lys Glu Asp Leu Ile Met Pro His
290 295 300
His His Thr Phe Tyr Glu Leu Ile Ile Ser Lys Ala Arg Gly Lys Ser
305 310 315 320
Gly Pro Leu Phe Asp Phe Thr Val Lys Asp Asp Ile Arg Ile Thr Asn
325 330 335
Asp Ala Thr Gln Glu Lys Gln Asp Thr His Ala Gly Lys Val Val Glu
340 345 350
Arg His Trp Tyr Asp Lys Asn Lys His Ile Phe Pro Ala Ser Arg Trp
355 360 365
Glu Ile Tyr Asp Pro Glu Lys Lys Tyr Gly Glu Tyr Thr Ile Tyr Gly
370 375 380
<210> 3
<211> 2118
<212> DNA
<213> artifical sequence
<400> 3
aattcgatct ggcacgacag gtttcccgac tggaaagcgg gcagtgagcg caacgcaatt 60
aatgtgagtt agctcactca ttaggcaccc caggctttac actttatgct tccggctcgt 120
atgttgtgtg gaattgtgag cggataacaa tttcacacag gaaacagcta tgaccatgat 180
tacgccaagc gcgcaattaa ccctcactaa agggaacaaa agctggagct ccaccgcggt 240
ggcggccgct ctagaactag tggatccact atagggcgaa ttggagctcc accgcggtgg 300
cggccgctct agagacggcg gggagctcgc tgaggcttga catgattggt gcgtatgttt 360
gtatgaagct acaggactga tttggcgggc tatgagggcg cgggaagctc tggaagggcc 420
gcgatggggc gcgcggcgtc cagaaggcgc catacggccc gctggcggca cccatccggt 480
ataaaagccc gcgaccccga acggtgacct ccactttcag cgacaaacga gcacttatac 540
atacgcgact attctgccgc tatacataac cactcagcta gcttaagatc ccatcaagct 600
tgcatgccgg gcgcgccaga aggagcgcag ccaaaccagg atgatgtttg atggggtatt 660
tgagcacttg caacccttat ccggaagccc cctggcccac aaaggctagg cgccaatgca 720
agcagttcgc atgcagcccc tggagcggtg ccctcctgat aaaccggcca gggggcctat 780
gttctttact tttttacaag agaagtcact caacatctta aaatggccag gtgagtcgac 840
gagcaagccc ggcggatcag gcagcgtgct tgcagatttg acttgcaacg cccgcattgt 900
gtcgacgaag gcttttggct cctctgtcgc tgtctcaagc agcatctaac cctgcgtcgc 960
cgtttccatt tgcaggatgg ccactccgcc ctccccggtg ctgaagaatt tcgaagcatg 1020
gacgatgcgt tgcgtgcact gcggggtcgg tatcccggtt gtgagtgggt tgttgtggag 1080
gatggggcct cgggggctgg tgtttatcgg cttcggggtg gtgggcggga gttgtttgtc 1140
aaggtggcag ctctgggggc cggggtgggc ttgttgggtg aggctgagcg gctggtgtgg 1200
ttggcggagg tggggattcc cgtacctcgt gttgtggagg gtggtgggga cgagagggtc 1260
gcctggttgg tcaccgaagc ggttccgggg cgtccggcca gtgcgcggtg gccgcgggag 1320
cagcggctgg acgtggcggt ggcgctcgcg gggctcgctc gttcgctgca cgcgctggac 1380
tgggagcggt gtccgttcga tcgcagtctc gcggtgacgg tgccgcaggc ggcccgtgct 1440
gtcgctgaag ggagcgtcga cttggaggat ctggacgagg agcggaaggg gtggtcgggg 1500
gagcggcttc tcgccgagct ggagcggact cggcctgcgg acgaggatct ggcggtttgc 1560
cacggtcacc tgtgcccgga caacgtgctg ctcgaccctc gtacctgcga ggtgaccggg 1620
ctgatcgacg tggggcgggt cggccgtgcg gaccggcact ccgatctcgc gctggtgctg 1680
cgcgagctgg cccacgagga ggacccgtgg ttcgggccgg agtgttccgc ggcgttcctg 1740
cgggagtacg ggcgcgggtg ggatggggcg gtatcggagg aaaagctggc gttttaccgg 1800
ctgttggacg agttcttctg agggacctga tggtgttggt ggctgggtag ggttgcgtcg 1860
cgtgggtgac agcacagtgt ggacgttggg atccccgctc cgtgtaaatg gaggcgctcg 1920
ttgatctgag ccttgccccc tgacgaacgg cggtggatgg aagatactgc tctcaagtgc 1980
tgaagcggta gcttagctcc ccgtttcgtg ctgatcagtc tttttcaaca cgtaaaaagc 2040
ggaggagttt tgcaattttg ttggttgtaa cgatcctccg ttgattttgg cctctttctc 2100
catgggcggg ctggaatt 2118
Claims (8)
1. a kind of cilium assembly and regulation gene, it is characterised in that:The gene source is in Chlamydomonas reinhardtii, the Gene Name
XAP5, the gene include such as SEQ ID NO:CDNA sequence shown in 1;Or include SEQ ID NO:Egg is encoded shown in 2
The polynucleotides of white matter sequence;Or comprising with SEQ ID NO:CDNA sequence defined by 1 with 90% or more it is homologous
Property and the nucleotide sequence for encoding identical function albumen.
2. the acquisition methods of cilium assembly and regulation gene as described in claim 1, it is characterised in that:Include the following steps:
It will be in the VIII segment radom insertions to chlamydomonas of aph that encode paromomycin resistance by electroporated method;It is obtained by screening
Cilium assembles deficiency mutation algae strain af1-x;It identifies to obtain the gene XAP5 for cilium assembly and regulation by RESDA-PCR.
3. the acquisition methods of cilium assembly and regulation gene according to claim 2, it is characterised in that:VIII segments of the aph
Sequence such as SEQ ID NO:Shown in 3.
4. the coding albumen of cilium assembly and regulation gene as described in claim 1, the coding albumen contains SEQ ID NO:2 institutes
The amino acid sequence shown, or comprising by SEQ ID NO:Amino acid sequence shown in 2 passes through the substitution of multiple amino acid, missing
Or addition formation has identical active derived protein.
5. the expression vector containing cilium assembly and regulation gene as described in claim 1.
6. the host cell containing cilium assembly and regulation gene as described in claim 1.
7. the expression vector acquisition methods containing cilium assembly and regulation gene as described in claim 1, include the following steps:
Wild type chlamydomonas RNA is extracted, reverse transcription obtains cDNA;Design primer obtains XAP5 genes by PCR amplification;By XAP5
Gene is connected to intermediate carrier or chlamydomonas expression vector.
8. the acquisition methods of the expression vector containing cilium assembly and regulation gene as described in claim 1, include the following steps:
The artificial synthesized cilium assembly and regulation gene order, carrier construction.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810210290.0A CN108424909B (en) | 2018-03-14 | 2018-03-14 | Cilium assembly regulatory gene and encoding protein, acquisition method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810210290.0A CN108424909B (en) | 2018-03-14 | 2018-03-14 | Cilium assembly regulatory gene and encoding protein, acquisition method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108424909A true CN108424909A (en) | 2018-08-21 |
CN108424909B CN108424909B (en) | 2021-11-30 |
Family
ID=63158381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810210290.0A Active CN108424909B (en) | 2018-03-14 | 2018-03-14 | Cilium assembly regulatory gene and encoding protein, acquisition method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108424909B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112062827A (en) * | 2020-09-16 | 2020-12-11 | 军事科学院军事医学研究院生物医学分析中心 | Application of CEP55 protein in regulation of cilia de-assembly and preparation of cilia-related disease model |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1137772A1 (en) * | 1998-12-10 | 2001-10-04 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Spermatogenesis protein |
CN106520756A (en) * | 2016-11-16 | 2017-03-22 | 江汉大学 | Screening method of chlamydomonas reinhardtii selenium-rich mutant |
-
2018
- 2018-03-14 CN CN201810210290.0A patent/CN108424909B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1137772A1 (en) * | 1998-12-10 | 2001-10-04 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Spermatogenesis protein |
CN106520756A (en) * | 2016-11-16 | 2017-03-22 | 江汉大学 | Screening method of chlamydomonas reinhardtii selenium-rich mutant |
Non-Patent Citations (2)
Title |
---|
HU,Z.等: "KU361202.1", 《GENBANK》 * |
LILI LI等: "New class of transcription factors controls flagellar assembly by recruiting RNA polymerase II in Chlamydomonas", 《PNAS》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112062827A (en) * | 2020-09-16 | 2020-12-11 | 军事科学院军事医学研究院生物医学分析中心 | Application of CEP55 protein in regulation of cilia de-assembly and preparation of cilia-related disease model |
CN112062827B (en) * | 2020-09-16 | 2022-10-21 | 中国人民解放军军事科学院军事医学研究院 | Application of CEP55 protein in regulation of cilia de-assembly and preparation of cilia-related disease model |
Also Published As
Publication number | Publication date |
---|---|
CN108424909B (en) | 2021-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105646684B (en) | A kind of rice grain shape GAP-associated protein GAP GLW2 and its encoding gene and application | |
CN111235180A (en) | Method for shortening flowering phase of corn | |
CN112538492A (en) | SpCas9n variant capable of recognizing NRTH (Polyacrylamide) as PAM (Polyacrylamide) sequence and corresponding base editing system | |
CN107099544A (en) | The PL LbCpf1 RVR genes of identification specific site and its application in paddy gene target practice | |
CN107142271A (en) | The PL LbCpf1 RR genes with high mutation efficiency and its application in gene targeting | |
CN107353332A (en) | A kind of rice chloroplast developmental regulation Gene A HS1 and its coding protein and application | |
CN108424909A (en) | A kind of cilium assembly and regulation gene and its coding albumen, acquisition methods and application | |
CN101935342A (en) | Moth orchid development B gene-PhAP3 coded sequence and application thereof | |
CN109929857A (en) | A kind of high editorial efficiency SaCas9 gene and its application | |
CN109293752A (en) | Yersinia pestis virulence-associated protein sORF17 and its encoding gene and application | |
CN112646820B (en) | Gene and method for changing flowering period of corn | |
CN112813079A (en) | Danbo black soybean GmFER84 gene and application thereof in soybean aluminum stress improvement | |
CN105399806B (en) | A kind of relevant albumen of rice male and female fertility, its encoding gene and its application | |
CN106397562B (en) | Application of the protein G mGATA44 in regulation plant grain weight | |
CN114539389B (en) | Recombinant collagen and application thereof | |
CN112724215B (en) | Gene and method for changing flowering period of corn | |
CN112626050B (en) | SpCas9-NRCH mutant for recognizing specific sites in rice gene targeting and application thereof | |
CN112646014B (en) | Gene and method for changing flowering period of corn | |
CN112724216B (en) | Gene and method for changing flowering period of corn | |
CN112646015B (en) | Gene and method for changing flowering period of corn | |
CN106754995A (en) | Apis cerana AccCDK5 genes and AccCDK5r1 genes and its application | |
CN108707574A (en) | One plant of yielding lipase engineering bacteria, its construction method and application | |
CN112661823B (en) | Gene and method for changing flowering period of corn | |
CN114292943B (en) | Application of tomato SlC H39 gene as negative regulatory factor in improving low temperature resistance of tomato | |
CN110699363B (en) | Rice retrotransposon gene LOC _ Os11g45295, and coding protein and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240407 Address after: 4-23, unit 1, 4 / F, 2 Zhengda Road, Shijingshan District, Beijing Patentee after: Beijing gengtianxia Biotechnology Co.,Ltd. Country or region after: China Address before: 430056 No. 8 Xinjiang road, Zhuankou economic and Technological Development Zone, Wuhan, Hubei Patentee before: JIANGHAN University Country or region before: China |